Closed formularies hold the line on costs

Health plans struggling to rein in pharmacy costs are using mail service, disease management programs, financial incentives for generics, member cost sharing, and, increasingly, limited and closed formularies. » Feature story

From transparency to clarity

Transparency is only the first step toward driving improvement in our healthcare system. To see real change, we also need clarity.
» Commentary

Study finds PCMHs improve cancer screening rates

Blue Cross Blue Shield of Michigan's patient-centered medical home program has been shown to lower costs and improve patient outcomes. » Study results

Genetic variants determine whether aspirin/NSAIDS will reduce colorectal cancer risk

Regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) appears to reduce the risk of colorectal cancer in most individuals, according to a new study published in JAMA.
» Details

IN CASE YOU MISSED IT

• A health plan tackles opioid addiction

• Consumers want price transparency but obstacles remain

• Covered the HIPPA bases? Don't forget about streaming media

Keep in touch with MHE

We value your input. Please send your comments and article ideas to [email protected].